Growth, Risks of Allergy and Metabolic Syndrome in 6 Year Old Children Born Preterm Compared to Postdischarge Nutrition
Infant, Very Low Birth Weight, Metabolic Syndrome, Protection Against, Allergy
About this trial
This is an interventional treatment trial for Infant, Very Low Birth Weight focused on measuring very preterm, nutrition, 6 year follow-up, growth, metabolic syndrome, allergy, dexa
Eligibility Criteria
Inclusion Criteria:
- Participated in the original study when they were discharge from hospital
- Parents accept of participation in the 6 year follow-up
Exclusion Criteria:
- Participation not accepted by parents
- Genetic diseases with influence on growth
Sites / Locations
- HC Anderson Children´s Hospital, OUH
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Group 1, HM
Group 2, HMF
Group 3, PF
This group received breastfeeding (human milk, HM) solely throughout the 4 month of intervention. Randomisation for group 1 or group 2. Mothers own milk.
This group received mothers own milk with fortification (human milk fortification, HMF) throughout the 4 month intervention period. Randomisation for group 1 og group 2. Enfamil HM fortifier, Mead Johnson.
This group received preterm formula (PF) throughout the intervention period of 4 month. This group was not randomised for ethical reasons. Enfalac Premature Formula, Mead Johnson Nutritionals